Ravulizumab 100 mg/mL, concentrate for solution for infusion, I.V.

By: Jorge Pineda๐Ÿ“ PanamaClosed

Key Information

ReferenceGB-2026-1-10-01-08-SLP-000821
DeadlineOct 28, 2026 12:00 AM
CategoryAdvertising & Media
Competition TypeICB
Funding SourceSelf-Funded
CountryPanama
AddressPA
PublishedOct 20, 2026

Description

RAVULIZUMAB

Full details are available after unlocking this tender.